Edgewise Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EWTX Nasdaq 2830 edgewisetx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Edgewise Therapeutics, Inc.

Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference - Jun 3rd, 2025 6:00 am
All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy - May 19th, 2025 10:00 am
Treehouse Foods, GeneDx Holdings See Activist Action - May 16th, 2025 3:55 pm
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - May 14th, 2025 7:55 am
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 - May 14th, 2025 6:00 am
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - May 8th, 2025 6:00 am
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - May 5th, 2025 5:57 am
Why Edgewise Therapeutics Stock Popped This Week - May 2nd, 2025 5:07 pm
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Apr 25th, 2025 2:31 pm
Bristol Myers stumbles in bid to widen heart drug’s use - Apr 15th, 2025 4:00 am
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb - Apr 10th, 2025 3:00 am
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More - Apr 9th, 2025 11:45 am
Edgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Apr 8th, 2025 7:33 pm
EWTX Stock Down 48% in a Week Despite Upbeat Cardiomyopathy Study Data - Apr 7th, 2025 10:17 am
Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money - Apr 5th, 2025 3:29 pm
Edgewise Therapeutics Downgraded Following Safety Issues in Heart Drug Trial - Apr 3rd, 2025 12:16 pm
Edgewise Therapeutics Says Believes Atrial Fibrillation Not Driven by EDG-7500 in Phase 2 Trial, RBC Says - Apr 3rd, 2025 10:36 am
Why Edgewise Therapeutics And Cytokinetics Stocks Just Diverged - Apr 2nd, 2025 2:36 pm
Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events' - Apr 2nd, 2025 1:02 pm
Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock - Apr 2nd, 2025 4:22 am